Randomised, double‐blind, placebo‐controlled studies on flurbiprofen 8.75 mg lozenges in patients with/without group A or C streptococcal throat infection, with an assessment of clinicians' prediction of ‘strep throat’

Publisher: John Wiley & Sons Inc

E-ISSN: 1742-1241|69|1|59-71

ISSN: 1368-5031

Source: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol.69, Iss.1, 2015-01, pp. : 59-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content